Dpp-4 Inhibitor Archives - Diabetes Health

BALTIMORE-Researchers at the University of Maryland School of Medicine are enrolling patients with type 2 diabetes into an NIH-funded clinical

Lilly Begins Sales of Jentadueto, a Combo Drug for Type 2s

Eli Lilly and Company has begun US sales of Jentadueto, a drug for type 2 diabetes that combines Tradjenta and

The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin

Combination therapy, in which doctors prescribe more than one drug to treat type 2 diabetes, is a fairly common practice.